- Tytuł:
- Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
- Autorzy:
- Źródło:
- In The Lancet Neurology January 2024 23(1):46-59
Czasopismo naukowe